ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,091Medicare Part D Prescriptions Filled, Including Refills

Rank: 121 out of 1269

$632K Total Retail Price of All Prescriptions

Rank: 76 out of 1269

373 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 373 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 373 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

3% of this provider’s 6,523 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
PRAVASTATIN SODIUM 312 266 1 11
MELOXICAM 273 192 2 68
FUROSEMIDE 236 210 3 5
LISINOPRIL 234 184 4 1
AMLODIPINE BESYLATE 187 179 5 2
SIMVASTATIN 183 137 6 3
LEVOTHYROXINE SODIUM 140 112 7 4
ATORVASTATIN CALCIUM 135 119 8 7
METOPROLOL TARTRATE 132 109 9 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 127 108 10 33
ZOLPIDEM TARTRATE 116 84 11 19
SPIRIVA 107 98 12 64
OMEPRAZOLE 105 70 13 8
CELEBREX 104 104 14 95
GLYBURIDE 104 88 R 14 94
IPRATROPIUM BROMIDE 97 62 16 127
PANTOPRAZOLE SODIUM 88 70 17 18
HYDROCODONE-ACETAMINOPHEN 87 61 S3 18 20
GLIMEPIRIDE 87 87 18 57
AZITHROMYCIN 86 67 20 42
HYDROCHLOROTHIAZIDE 86 66 20 10
AMLODIPINE BESYLATE-BENAZEPRIL 84 80 22 81
TRIAMTERENE-HCTZ 80 63 23 69
PROAIR HFA 79 59 24 61
KLOR-CON M20 79 67 24 60
SERTRALINE HCL 79 59 24 23
OXYCODONE HCL 78 17 S2 27 34
ATENOLOL 74 65 28 14
METOPROLOL SUCCINATE 71 62 29 13
TRICOR 66 63 30 152
ONGLYZA 63 63 31 308
METFORMIN HCL 62 53 32 9
MIRTAZAPINE 61 61 33 24
ADVAIR DISKUS 61 45 33 46
CRESTOR 57 45 35 25
CITALOPRAM HBR 56 50 36 21
CLOPIDOGREL 53 43 37 32
FENOFIBRATE 53 52 37 115
TAMSULOSIN HCL 51 50 39 31
BENICAR 51 51 39 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.